For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Next-level Sensitivity for the Quantification of Warfarin and Furosemide in Human Plasma
In this application, Warfarin and Furosemide were extracted from human plasma and quantified using a negative ion mode approach on the SCIEX 7500 system and a Kinetex C18 core-shell LC column. The improved front-end technology of the column and system enabled greater ion generation, capture and transmission to improve sensitivity for routine bioanalysis.
Next-level Sensitivity for the Quantification of Warfarin and Furosemide in Human Plasma
In this application, Warfarin and Furosemide were extracted from human plasma and quantified using a negative ion mode approach on the SCIEX 7500 system and a Kinetex C18 core-shell LC column. The improved front-end technology of the column and system enabled greater ion generation, capture and transmission to improve sensitivity for routine bioanalysis.
Document Type:
Technical Notes
Target Industries:
Pharmaceutical
Techniques:
HPLC
Brands:
Kinetex
Separation Modes:
Reversed Phase
Phases:
Kinetex C18
save_alt Download
favorite_border
Phenomenex logo
Headquarters
411 Madrid Avenue, Torrance, CA 90501
t: (310) 212-0555 f: (310) 328-7768

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

OUR COMPANY 

About Phenomenex

Our Humanity

Our People

Blog

Danaher Life Sciences

Stay up to date on the latest from Phenomenex
Iso logo
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Cookie Settings © 2023 Phenomenex Inc. All rights reserved.